Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis
Objectives: Women with Rheumatoid Arthritis (RA) can experience flares during pregnancy that might influence pregnancy outcomes. We aimed at assessing the disease course during pregnancy and identifying risk factors for flares.Methods: Data about prospectively-followed pregnancies in RA were retrosp...
Saved in:
Main Authors: | Maria Chiara Gerardi (Author), Francesca Crisafulli (Author), Antía García-Fernandez (Author), Daniele Lini (Author), Chiara Bazzani (Author), Ilaria Cavazzana (Author), Matteo Filippini (Author), Micaela Fredi (Author), Roberto Gorla (Author), Maria Grazia Lazzaroni (Author), Cecilia Nalli (Author), Marco Taglietti (Author), Andrea Lojacono (Author), Francesca Ramazzotto (Author), Cristina Zanardini (Author), Sonia Zatti (Author), Franco Franceschini (Author), Angela Tincani (Author), Laura Andreoli (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
by: Juthamas Prawjaeng, et al.
Published: (2023) -
Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2021) -
Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database
by: Shuang Xia, et al.
Published: (2024) -
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
by: Maria-Grazia Lazzaroni, et al.
Published: (2020) -
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
by: Van De Laar CJ, et al.
Published: (2020)